Eagle Pharmaceuticals, Inc.
EGRX
Revenue
64.65M
▼-1.66M▼-2.50%
3 Months ChangeAssets
404.82M
▼-9.35M▼-2.26%
3 Months ChangeLiabilities
152.78M
▼-18.55M▼-10.83%
3 Months ChangeFree Cash Flow
-33.57M
▼-16.79M▼-100.07%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 8-K
ID: 0001104659-24-112887
2024-10-02
Form 8-K
ID: 0001104659-24-105232
2024-08-27
Form 8-K
ID: 0001104659-24-093448
2024-08-05
Form 8-K
ID: 0001104659-24-085668
2024-07-10
Form 8-K
ID: 0001104659-24-078777
2024-05-29
Form 8-K
ID: 0001104659-24-065884
2024-05-22
Form 8-K
ID: 0001104659-24-064099
2024-05-15
Form 8-K
ID: 0001104659-24-061683
2024-04-12
Form 8-K
ID: 0001104659-24-046776
2024-03-08
Form 8-K
ID: 0001104659-24-032458